Patent US4810487A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4810487A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of identifying polymethine stained lymphocyte subpopulations and compositions thereof

Assignee: CYTOCOLOR Inc A CORP OF OH
•
Filing: 1986-01-02
•
Granted: 1989-03-07
•
Expires: 2006-01-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention is directed to the use of specific polymethine dyes for staining fixed biopsy specimens of hematopoietic origin consisting of blood, bone marrow and lymph node cells for purposes of identifying and enumerating the stained cells when viewed under dark field illumination. The polymethine dyes, e.g. Astrazon Red Violet FRR, stain the lymphocyte subpopulations distinct colors capable of being viewed under dark field illumination for purposes of distinguishing one stained cell from another. This method of staining and the compositions thereof represents an advance in the art of lymphocyte subpopulation identification which was achieved heretofore primarily by using monoclonal antibody techniques.

Inventors

  • 👤 Lawrence Kass

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 18:58
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5094; G01N1/00; G01N1/28; G01N1/30; G01N2001/305; Y; Y10; Y10S; Y10S436/00; Y10S436/805; Y10S436/811; Y10T; Y10T436/00; Y10T436/25; Y10T436/2525

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 114 words
A method for differentiating, identifying and enumerating lymphocytes from one another among a plurality of cells of hematopoietic origin selected from the group consisting of blood cells, bone marrow cells and lymph node cells which comprises fixing a biopsy specimen of said cells in a fixative and subsequently staining said fixed cells with a staining amount of a polymethine dye to obtain a plurality of stained cells having individual color characteristics which permit the differentiation, identification and enumeration of the lymphocytes from one another and from a plurality of cells; said polymethine dye having the formula: ##STR5## wherein R is a substituent selected from the group consisting of hydrogen, chlorine and CH 3 --O--C═O.
Claim 2
Independent Claim 114 words
A method for differentiating, identifying and enumerating lymphocytes from one another among a plurality of cells of hematopoietic origin selected from the group consisting of blood cells, bone marrow cells and lymph node cells which comprises fixing a biopsy specimen of said cells in a fixative and subsequently staining said fixed cells with a staining amount of a polymethine dye to obtain a plurality of stained cells having individual color characteristics which permit the differentiation, identification and enumeration of the lymphocytes from one another and from a plurality of cells; said polymethine dye having the formula: ##STR5## wherein R is a substituent selected from the group consisting of hydrogen, chlorine and CH 3 --O--C═O.
Claim 3
Dependent Claim 32 words
The method of claim 1 further characterized in that the stained lymphocytes have color characteristics which permit the differentiation, identification and enumeration of said lymphocytes with an instrument under dark field illumination.
Claim 4
Dependent Claim 19 words
The method of claim 1 further characterized in that the polymethine dye has the formula wherein R is hydrogen.
Claim 5
Dependent Claim 21 words
The method of claim 1 further characterized in that the polymethine dye has the formula wherein R is CH 3 --O--C═O.
Claim 6
Dependent Claim 19 words
The method of claim 1 further characterized in that the polymethine dye has the formula wherein R is chlorine.
Claim 7
Dependent Claim 17 words
The method of claim 1 further characterized in that the cells of hematopoietic origin are blood cells.
Claim 8
Dependent Claim 34 words
The method of claim 1 further characterized in that the cells of hematopoietic origin are cells having a subpopulation comprising T-helper cells, T-suppressor cells, B-cells, Natural Killer cells, eosinophils, basophils, neutrophils, monocytes, and platelets.
Claim 9
Dependent Claim 17 words
The method of claim 1 further characterized in that the fixative comprises a lower molecular weight alcohol.
Claim 10
Dependent Claim 13 words
The method of claim 1 further characterized in that the fixative comprises formaldehyde.
Claim 11
Dependent Claim 23 words
The method of claim 8 further characterized in that the fixative contains up to about 1.0 percent by weight of the polymethine dye.
Claim 12
Dependent Claim 28 words
The method of claim 1 further characterized in that the fixed cells are subsequently stained with the polymethine dye in an aqueous solution containing an alkaline buffering agent.
Claim 13
Dependent Claim 37 words
The method of claim 1 further characterized in that the cells are fixed in the fixative and then subsequently stained by the addition of staining amounts of an aqueous solution of the polymethine dye to the fixative.
Claim 14
Dependent Claim 31 words
The method of claim 12 further characterized in that an effective amount of an alkaline buffering agent is added to the aqueous solution of the polymethine dye to increase the pH.
Claim 15
Dependent Claim 36 words
The method of claim 13 further characterized in that the polymethine dye is present in the aqueous solution of the alkaline buffering agent in amounts ranging up to about 2.0 percent by weight of the solution.
Claim 16
Dependent Claim 41 words
The method of claim 1 further characterized in that the cells of hematopoietic origin are fixed in a solution containing ethyl alcohol and subsequently stained with an aqueous buffered solution of a polymethine dye having the formula wherein R is hydrogen.
Claim 17
Dependent Claim 35 words
The method of claim 1 further characterized in that the cells of hematopoietic origin are blood cells having a subpopulation comprising monocytes, platelets, eosinophils, basophils, neutrophils, T-suppressor cells, T-helper cells, B-cells, and Natural Killer cells.
Claim 18
Dependent Claim 22 words
The method of claim 16 further characterized in that the cells of hematopoietic origin comprise blood cells containing or surrounded by parasites.
Claim 19
Dependent Claim 17 words
The method of claim 16 further characterized in that the cells of hematopoietic origin comprise malignant cells.
Claim 20
Dependent Claim 18 words
The method of claim 1 further characterized in that the cells of hematopoietic origin comprise malignant blood cells.
Claim 21
Dependent Claim 32 words
The method of claim 16 further characterized in that the color characteristics of the stained cells permit the differentiation, identification and enumeration of said cells with an instrument under dark field illumination.
Claim 22
Dependent Claim 76 words
A plurality of cells of hematopoietic origin selected from the group consisting of blood cells, bone marrow cells, and lymph node cells fixed and stained with a polymethine dye; said stained cells having color characteristics which permit the differentiation, identification and enumeration of each stained cell among a plurality of the cells; said polymethine dye having the formula: ##STR6## wherein R is a substituent selected from the group consisting of hydrogen, chlorine and CH 3 --O--C═O.
Claim 23
Dependent Claim 76 words
A plurality of cells of hematopoietic origin selected from the group consisting of blood cells, bone marrow cells, and lymph node cells fixed and stained with a polymethine dye; said stained cells having color characteristics which permit the differentiation, identification and enumeration of each stained cell among a plurality of the cells; said polymethine dye having the formula: ##STR6## wherein R is a substituent selected from the group consisting of hydrogen, chlorine and CH 3 --O--C═O.
Claim 24
Dependent Claim 22 words
The plurality of stained cells of claim 21 further characterized in that the polymethine dye has the formula wherein R is hydrogen.
Claim 25
Dependent Claim 24 words
The plurality of stained cells of claim 21 further characterized in that the polymethine dye has the formula wherein R is CH 3 --O--C═O.
Claim 26
Dependent Claim 22 words
The plurality of stained cells of claim 21 further characterized in that the polymethine dye has the formula wherein R is chlorine.
Claim 27
Dependent Claim 32 words
The plurality of stained cells of claim 22 further characterized as stained blood cells having a subpopulation comprising T-helper cells, T-suppressor cells, B-cells, Natural Killer cells, neutrophils, basophils, eosinophils, monocytes, and platelets.
Claim 28
Dependent Claim 14 words
The plurality of stained cells of claim 22 further characterized as stained lymphocyte subpopulation.
Claim 29
Dependent Claim 19 words
The plurality of stained cells of claim 26 further characterized in that the stained lymphocyte subpopulation comprise malignant cells.
Claim 30
Dependent Claim 26 words
The plurality of stained cells of claim 21 further characterized as stained human blood cells of hematopoietic origin comprising lymphocyte subpopulation containing or surrounded by parasites.
Claim 31
Dependent Claim 28 words
The plurality of stained cells of claim 28 further characterized in that the lymphocyte subpopulation are stained with the polymethine dye having the formula wherein R is hydrogen.
Claim 32
Dependent Claim 36 words
The plurality of stained cells of claim 21 further characterized in that the color characteristics of the stained cells permit the differentiation, identification and enumeration of the stained lymphocyte with an instrument under dark field illumination.

References Cited (Backward Citations)

US4400370A Cited
US4581223A Cited
US4615878A Cited
US4500509A Cited
US4513142A Cited
US4714606A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-06 1992-09-05 1993-03-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-06 1996-09-05 1997-03-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-06 2000-09-05 2001-03-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag